Casticin-Induced Inhibition of Cell Growth and Survival Are Mediated Through the Dual Modulation of Akt/mTOR Signaling Cascade

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2019 Mar 1

PMID 30813295

Citations 29

Authors

Jong Hyun Lee

Chulwon Kim

Jae-Young Um

Gautam Sethi

Kwang Seok Ahn

Affiliations

Soon will be listed here.

Abstract

The Akt/mTOR signaling cascade is a critical pathway involved in various physiological and pathological conditions, including regulation of cell proliferation, survival, invasion, and angiogenesis. In the present study, we investigated the anti-neoplastic effects of casticin (CTC), identified from the plant L., alone and/or in combination with BEZ-235, a dual Akt/mTOR inhibitor in human tumor cells. We found that CTC exerted a significant dose-dependent cytotoxicity and reduced cell proliferation in a variety of human tumor cells. Also, CTC effectively blocked the phosphorylation levels of Akt (Ser473) and mTOR (Ser2448) proteins as well as induced substantial apoptosis. Additionally treatment with CTC and BEZ-235 in conjunction resulted in a greater apoptotic effect than caused by either agent alone thus implicating the anti-neoplastic effects of this novel combination. Overall, the findings suggest that CTC can interfere with Akt/mTOR signaling cascade involved in tumorigenesis and can be used together with pharmacological agents targeting Akt/mTOR pathway.

Citing Articles

Wnt/β-catenin signaling pathway: an attractive potential therapeutic target in osteosarcoma.

Ding Y, Chen Q Front Oncol. 2025; 14:1456959.

PMID: 40028002 PMC: 11867957. DOI: 10.3389/fonc.2024.1456959.

Mechanisms of Postischemic Stroke Angiogenesis: A Multifaceted Approach.

Hu B, Pei J, Wan C, Liu S, Xu Z, Zou Y J Inflamm Res. 2024; 17:4625-4646.

PMID: 39045531 PMC: 11264385. DOI: 10.2147/JIR.S461427.

Potential Impact of Bioactive Compounds as NLRP3 Inflammasome Inhibitors: An Update.

Singh S, Sharma S, Sharma H Curr Pharm Biotechnol. 2024; 25(13):1719-1746.

PMID: 38173061 DOI: 10.2174/0113892010276859231125165251.

Molecular mechanism underlying epithelial-mesenchymal transformation and cisplatin resistance in esophageal squamous cell carcinoma.

Song K, Ma C, Gu B, Wang B, Ma H, Deng X Thorac Cancer. 2023; 14(31):3069-3079.

PMID: 37718469 PMC: 10626249. DOI: 10.1111/1759-7714.15094.

CircRNA PGAM1 Promotes the Migration and Invasion of Pancreatic Adenocarcinoma Cells by Activating the AKT/mTOR Signaling Pathway.

Wang F, Yan X, Peng X, Liu D, Bu W, Kang F Mol Biotechnol. 2023; 66(9):2341-2348.

PMID: 37702882 DOI: 10.1007/s12033-023-00865-1.

References

Ko W, Kang T, Lee S, Kim N, Kim Y, Sohn D . Polymethoxyflavonoids from Vitex rotundifolia inhibit proliferation by inducing apoptosis in human myeloid leukemia cells. Food Chem Toxicol. 2000; 38(10):861-5. DOI: 10.1016/s0278-6915(00)00079-x. View

Abraham R . Cell cycle checkpoint signaling through the ATM and ATR kinases. Genes Dev. 2001; 15(17):2177-96. DOI: 10.1101/gad.914401. View

Zhang W, Liu H . MAPK signal pathways in the regulation of cell proliferation in mammalian cells. Cell Res. 2002; 12(1):9-18. DOI: 10.1038/sj.cr.7290105. View

Newman D, Cragg G, Snader K . Natural products as sources of new drugs over the period 1981-2002. J Nat Prod. 2003; 66(7):1022-37. DOI: 10.1021/np030096l. View

Herbst R . Review of epidermal growth factor receptor biology. Int J Radiat Oncol Biol Phys. 2004; 59(2 Suppl):21-6. DOI: 10.1016/j.ijrobp.2003.11.041. View

Haidara K, Zamir L, Shi Q, Batist G . The flavonoid Casticin has multiple mechanisms of tumor cytotoxicity action. Cancer Lett. 2006; 242(2):180-90. DOI: 10.1016/j.canlet.2005.11.017. View

Sethi G, Ahn K, Chaturvedi M, Aggarwal B . Epidermal growth factor (EGF) activates nuclear factor-kappaB through IkappaBalpha kinase-independent but EGF receptor-kinase dependent tyrosine 42 phosphorylation of IkappaBalpha. Oncogene. 2007; 26(52):7324-32. DOI: 10.1038/sj.onc.1210544. View

Manning B, Cantley L . AKT/PKB signaling: navigating downstream. Cell. 2007; 129(7):1261-74. PMC: 2756685. DOI: 10.1016/j.cell.2007.06.009. View

Aggarwal B, Sethi G, Baladandayuthapani V, Krishnan S, Shishodia S . Targeting cell signaling pathways for drug discovery: an old lock needs a new key. J Cell Biochem. 2007; 102(3):580-92. DOI: 10.1002/jcb.21500. View

10.

Lin S, Zhang H, Han T, Wu J, Rahman K, Qin L . In vivo effect of casticin on acute inflammation. Zhong Xi Yi Jie He Xue Bao. 2007; 5(5):573-6. DOI: 10.3736/jcim20070520. View

11.

Deorukhkar A, Krishnan S, Sethi G, Aggarwal B . Back to basics: how natural products can provide the basis for new therapeutics. Expert Opin Investig Drugs. 2007; 16(11):1753-73. DOI: 10.1517/13543784.16.11.1753. View

12.

Carnero A, Blanco-Aparicio C, Renner O, Link W, Leal J . The PTEN/PI3K/AKT signalling pathway in cancer, therapeutic implications. Curr Cancer Drug Targets. 2008; 8(3):187-98. DOI: 10.2174/156800908784293659. View

13.

Maira S, Stauffer F, Brueggen J, Furet P, Schnell C, Fritsch C . Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity. Mol Cancer Ther. 2008; 7(7):1851-63. DOI: 10.1158/1535-7163.MCT-08-0017. View

14.

Mesaik M, Murad S, Khan K, Tareen R, Ahmed A, Choudhary M . Isolation and immunomodulatory properties of a flavonoid, casticin from Vitex agnus-castus. Phytother Res. 2009; 23(11):1516-20. DOI: 10.1002/ptr.2492. View

15.

Sethi G, Tergaonkar V . Potential pharmacological control of the NF-κB pathway. Trends Pharmacol Sci. 2009; 30(6):313-21. DOI: 10.1016/j.tips.2009.03.004. View

16.

Harikumar K, Kunnumakkara A, Sethi G, Diagaradjane P, Anand P, Pandey M . Resveratrol, a multitargeted agent, can enhance antitumor activity of gemcitabine in vitro and in orthotopic mouse model of human pancreatic cancer. Int J Cancer. 2009; 127(2):257-68. PMC: 3090706. DOI: 10.1002/ijc.25041. View

17.

Li F, Sethi G . Targeting transcription factor NF-kappaB to overcome chemoresistance and radioresistance in cancer therapy. Biochim Biophys Acta. 2010; 1805(2):167-80. DOI: 10.1016/j.bbcan.2010.01.002. View

18.

Shanmugam M, Kannaiyan R, Sethi G . Targeting cell signaling and apoptotic pathways by dietary agents: role in the prevention and treatment of cancer. Nutr Cancer. 2011; 63(2):161-73. DOI: 10.1080/01635581.2011.523502. View

19.

Steelman L, Chappell W, Abrams S, Kempf R, Long J, Laidler P . Roles of the Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR pathways in controlling growth and sensitivity to therapy-implications for cancer and aging. Aging (Albany NY). 2011; 3(3):192-222. PMC: 3091517. DOI: 10.18632/aging.100296. View

20.

Park K, Nam D, Yun H, Lee S, Jang H, Sethi G . β-Caryophyllene oxide inhibits growth and induces apoptosis through the suppression of PI3K/AKT/mTOR/S6K1 pathways and ROS-mediated MAPKs activation. Cancer Lett. 2011; 312(2):178-88. DOI: 10.1016/j.canlet.2011.08.001. View